These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22438253)

  • 41. Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors.
    Sawada S; Gowrishankar K; Kitamura R; Suzuki M; Suzuki G; Tahara S; Koito A
    J Exp Med; 1998 May; 187(9):1439-49. PubMed ID: 9565636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The loss of Gnai2 and Gnai3 in B cells eliminates B lymphocyte compartments and leads to a hyper-IgM like syndrome.
    Hwang IY; Park C; Luong T; Harrison KA; Birnbaumer L; Kehrl JH
    PLoS One; 2013; 8(8):e72596. PubMed ID: 23977324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-level Cxcr4-haploinsufficient HSC engraftment is sufficient to correct leukopenia in WHIM syndrome mice.
    Gao JL; Owusu-Ansah A; Paun A; Beacht K; Yim E; Siwicki M; Yang A; Liu Q; McDermott DH; Murphy PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CXCL12 Mediates Aberrant Costimulation of B Lymphocytes in Warts, Hypogammaglobulinemia, Infections, Myelokathexis Immunodeficiency.
    Roselli G; Martini E; Lougaris V; Badolato R; Viola A; Kallikourdis M
    Front Immunol; 2017; 8():1068. PubMed ID: 28928741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [CXCR4, a therapeutic target in rare immunodeficiencies?].
    Bignon A; Biajoux V; Bouchet-Delbos L; Emilie D; Lortholary O; Balabanian K
    Med Sci (Paris); 2011 Apr; 27(4):391-7. PubMed ID: 21524404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of pertussis toxin-sensitive CXCL12 (SDF-1) receptors mediates transendothelial migration of T lymphocytes across lymph node high endothelial cells.
    Phillips R; Ager A
    Eur J Immunol; 2002 Mar; 32(3):837-47. PubMed ID: 11870628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hematologic disorder-associated Cxcr4 gain-of-function mutation leads to uncontrolled extrafollicular immune response.
    Alouche N; Bonaud A; Rondeau V; Hussein-Agha R; Nguyen J; Bisio V; Khamyath M; Crickx E; Setterblad N; Dulphy N; Mahevas M; McDermott DH; Murphy PM; Balabanian K; Espéli M
    Blood; 2021 Jun; 137(22):3050-3063. PubMed ID: 33512437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
    Geier CB; Ellison M; Cruz R; Pawar S; Leiss-Piller A; Zmajkovicova K; McNulty SM; Yilmaz M; Evans MO; Gordon S; Ujhazi B; Wiest I; Abolhassani H; Aghamohammadi A; Barmettler S; Bhar S; Bondarenko A; Bolyard AA; Buchbinder D; Cada M; Cavieres M; Connelly JA; Dale DC; Deordieva E; Dorsey MJ; Drysdale SB; Ehl S; Elfeky R; Fioredda F; Firkin F; Förster-Waldl E; Geng B; Goda V; Gonzalez-Granado L; Grunebaum E; Grzesk E; Henrickson SE; Hilfanova A; Hiwatari M; Imai C; Ip W; Jyonouchi S; Kanegane H; Kawahara Y; Khojah AM; Kim VH; Kojić M; Kołtan S; Krivan G; Langguth D; Lau YL; Leung D; Miano M; Mersyanova I; Mousallem T; Muskat M; Naoum FA; Noronha SA; Ouederni M; Ozono S; Richmond GW; Sakovich I; Salzer U; Schuetz C; Seeborg FO; Sharapova SO; Sockel K; Volokha A; von Bonin M; Warnatz K; Wegehaupt O; Weinberg GA; Wong KJ; Worth A; Yu H; Zharankova Y; Zhao X; Devlin L; Badarau A; Csomos K; Keszei M; Pereira J; Taveras AG; Beaussant-Cohen SL; Ong MS; Shcherbina A; Walter JE
    J Clin Immunol; 2022 Nov; 42(8):1748-1765. PubMed ID: 35947323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease.
    De Filippo K; Rankin SM
    Eur J Clin Invest; 2018 Nov; 48 Suppl 2(Suppl Suppl 2):e12949. PubMed ID: 29734477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation
    Janssens R; Boff D; Ruytinx P; Mortier A; Vanheule V; Larsen O; Daugvilaite V; Rosenkilde MM; Noppen S; Liekens S; Schols D; De Meester I; Opdenakker G; Struyf S; Teixeira MM; Amaral FA; Proost P
    Front Immunol; 2018; 9():1933. PubMed ID: 30233568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCR4 signaling in health and disease.
    Pozzobon T; Goldoni G; Viola A; Molon B
    Immunol Lett; 2016 Sep; 177():6-15. PubMed ID: 27363619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity.
    Nie Y; Waite J; Brewer F; Sunshine MJ; Littman DR; Zou YR
    J Exp Med; 2004 Nov; 200(9):1145-56. PubMed ID: 15520246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.
    Heusinkveld LE; Majumdar S; Gao JL; McDermott DH; Murphy PM
    J Clin Immunol; 2019 Aug; 39(6):532-556. PubMed ID: 31313072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plerixafor for the Treatment of WHIM Syndrome.
    McDermott DH; Pastrana DV; Calvo KR; Pittaluga S; Velez D; Cho E; Liu Q; Trout HH; Neves JF; Gardner PJ; Bianchi DA; Blair EA; Landon EM; Silva SL; Buck CB; Murphy PM
    N Engl J Med; 2019 Jan; 380(2):163-170. PubMed ID: 30625055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of CXC chemokine receptor type 4: putative therapeutic approaches in inflammatory diseases.
    Hummel S; Van Aken H; Zarbock A
    Curr Opin Hematol; 2014 Jan; 21(1):29-36. PubMed ID: 24275689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. WHIM Syndrome-linked CXCR4 mutations drive osteoporosis.
    Anginot A; Nguyen J; Abou Nader Z; Rondeau V; Bonaud A; Kalogeraki M; Boutin A; Lemos JP; Bisio V; Koenen J; Hanna Doumit Sakr L; Picart A; Coudert A; Provot S; Dulphy N; Aurrand-Lions M; Mancini SJC; Lazennec G; McDermott DH; Guidez F; Blin-Wakkach C; Murphy PM; Cohen-Solal M; Espéli M; Rouleau M; Balabanian K
    Nat Commun; 2023 Apr; 14(1):2058. PubMed ID: 37045841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing.
    Ryser MF; Ugarte F; Lehmann R; Bornhäuser M; Brenner S
    Mol Immunol; 2008 Nov; 46(1):166-71. PubMed ID: 18760838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysregulated stem cell niches and altered lymphocyte recirculation cause B and T cell lymphopenia in WHIM syndrome.
    Zehentmeier S; Lim VY; Ma Y; Fossati J; Ito T; Jiang Y; Tumanov AV; Lee HJ; Dillinger L; Kim J; Csomos K; Walter JE; Choi J; Pereira JP
    Sci Immunol; 2022 Sep; 7(75):eabo3170. PubMed ID: 36149943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cxcr4-haploinsufficient bone marrow transplantation corrects leukopenia in an unconditioned WHIM syndrome model.
    Gao JL; Yim E; Siwicki M; Yang A; Liu Q; Azani A; Owusu-Ansah A; McDermott DH; Murphy PM
    J Clin Invest; 2018 Aug; 128(8):3312-3318. PubMed ID: 29715199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
    Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
    J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.